Immediate-release medication is available as 5 mg and 10 mg tablets, whereas extended-release pills are available in 6.25 mg and 12.5 mg dosages
Smaller majorities of Hispanic and English-speaking Asian adults say the same (55% and 54%)
Management of heart failure should be initiated, and discontinuation or dose reduction of Avandia must be considered in such cases
The majority (67%) had Crohns disease (CD) and on advanced therapy (86%)
The primary sources for this report include: Recalls (Enforcement Reports Database) The Food and Drug Administration (FDA) categorizes product recalls in its Enforcement Report database based on the level of health risk, labeling them as Class I, II, III, or not yet classified. While the database includes drugs, food, cosmetics, medical devices, biologics, tobacco, and veterinary products, this report only covers selected drug recalls
After reconstitution, the vial goes straight into the refrigerator